📊 The healthcare sector often serves as a safe haven for investors, yet recent performance shows varied trends across different stocks. With a mix of positive and negative performances over three key periods, it's essential to delve deeper into their historical trends and potential future outlook.
| Stock | Performance (%) | Performance |
|---|---|---|
| LLY | 4.30% | |
| ABT | 3.67% | |
| ABBV | 3.27% | |
| AMGN | 3.57% | |
| JNJ | 2.46% | |
| TMO | 1.99% | |
| MRK | 1.39% | |
| UNH | 1.31% | |
| ISRG | -0.04% |
| Stock | Performance (%) | Performance |
|---|---|---|
| AMGN | 13.30% | |
| MRK | 11.91% | |
| JNJ | 9.03% | |
| ABT | 6.37% | |
| ABBV | 4.28% | |
| LLY | 2.64% | |
| UNH | 2.60% | |
| ISRG | 0.14% | |
| TMO | -10.19% |
| Stock | Performance (%) | Performance |
|---|---|---|
| MRK | 20.22% | |
| JNJ | 19.44% | |
| AMGN | 15.12% | |
| ABBV | 3.87% | |
| LLY | 1.29% | |
| UNH | -6.50% | |
| TMO | -10.92% | |
| ABT | -8.65% | |
| ISRG | -11.26% |
🔍 The analysis of healthcare stocks over different time frames presents a mixed bag. Over one week, LLY emerged as the top performer, while ISRG slightly lagged. Over the course of one month, AMGN demonstrated stellar returns, counteracted by TMO's negative trajectory. Stretching into three months, MRK surged ahead of its peers with JNJ not far behind. However, the likes of ISRG and TMO faced headwinds. Moving forward, investors should consider both short-term volatility and long-term resilience which are apparent across various equities in the healthcare sector. Tailored strategies focusing on specific stocks could yield optimal results in this dynamic sector.